Abstract
Nutraceuticals are largely used by general population. During the last decades, academicians and industries are intensifying the research of new bioactive compounds in order to improve the quality of life and to prevent disease in humans. The quality of the published research is however not always based on the rules of the Good Clinical Practice nor finalized to create a new Evidence-Based nutraceutical sciences. This chapter will resume some basic rules that we will expect to be applied to nutraceutical research in the next years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cicero AFG, Fogacci F, Colletti A. Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. Food Funct. 2017;8(6):2076–88. https://doi.org/10.1039/c7fo00178a.
Cicero AFG, Colletti A. Nutraceuticals and dietary supplements to improve quality of life and outcomes in heart failure patients. Curr Pharm Des. 2017;23(8):1265–72. https://doi.org/10.2174/1381612823666170124120518.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL. ESC/EAS guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281–344. https://doi.org/10.1016/j.atherosclerosis.2016.08.018.
Sut S, Baldan V, Faggian M, Peron G, Dall Acqua S. Nutraceuticals, a new challenge for medicinal chemistry. Curr Med Chem. 2016;23(28):3198–223.
Cicero AFG, Colletti A. An update on the safety of nutraceuticals and effects on lipid parameters. Expert Opin Drug Saf. 2018;17(3):303–13. https://doi.org/10.1080/14740338.2018.1429404.
McClements DJ, Li F, Xiao H. The nutraceutical bioavailability classification scheme: classifying Nutraceuticals according to factors limiting their Oral bioavailability. Annu Rev Food Sci Technol. 2015;6:299–327. https://doi.org/10.1146/annurev-food-032814-014043.
Fratter A, Semenzato A. New association of surfactants for the production of food and cosmetic nanoemulsions: preliminary development and characterization. Int J Cosmet Sci. 2011;33(5):443–9. https://doi.org/10.1111/j.1468-2494.2011.00652.x.
Fratter A, Frare C, Uras G, Bonini M, Casari Bariani E, Ragazzo B, Gaballo P, Longobardi P, Codemo C, Paoli A. New chitosan salt in gastro-resistant oral formulation could interfere with enteric bile salts emulsification of diet fats: preliminary laboratory observations and physiologic rationale. J Med Food. 2014;17(6):723–9. https://doi.org/10.1089/jmf.2013.0131.
Fratter A, Mason V, Pellizzato M, Valier S, Cicero AFG, Tedesco E, Meneghetti E, Benetti F. Lipomatrix: a novel ascorbyl palmitate-based lipid matrix to enhancing enteric absorption of Serenoa Repens oil. Int J Mol Sci. 2019;20(3):E669. https://doi.org/10.3390/ijms20030669.
Cicero AF, Petrini O, Prasad C. Clinical studies with nutraceuticals and how to carry them out. Curr Topics Nutr Res. 2017;15(2):63–6.
Lachin JM. Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales. PLoS One. 2014;9:e108784.
Fogacci F, Grassi D, Rizzo M, Cicero AFG. Metabolic effect of berberine-silymarin association: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Phytother Res. 2019;33(4):862–70. https://doi.org/10.1002/ptr.6282.
Fogacci F, Banach M, Mikhailidis DP, Bruckert E, Toth PP, Watts GF, Reiner Ž, Mancini J, Rizzo M, Mitchenko O, Pella D, Fras Z, Sahebkar A, Vrablik M, Cicero AFG. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP). Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2019;143:1–16. https://doi.org/10.1016/j.phrs.2019.02.028.
Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, VrablÃk M, Watts GF, Wong ND, Rizzo M. International Lipid Expert Panel (ILEP). The role of nutraceuticals in statin intolerant patients. J Am Coll Cardiol. 2018;72(1):96–118. https://doi.org/10.1016/j.jacc.2018.04.040.
Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, VrablÃk M, Wong ND, Banach M. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev. 2017;75(9):731–67. https://doi.org/10.1093/nutrit/nux047.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cicero, A.F.G., Rizzo, M. (2021). Future Perspectives in Nutraceutical Research. In: Cicero, A.F., Rizzo, M. (eds) Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-62632-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-62632-7_14
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-62631-0
Online ISBN: 978-3-030-62632-7
eBook Packages: MedicineMedicine (R0)